NABILONE / CESAMET a synthetic THC, CB 1 & CB 2 agonist and cannabis studies completed
Nabilone is chemically related to marijuana and belongs to the class of medications called cannabinoids.
Medical Marijuana: In Canada, the United States, the United Kingdom and Mexico, nabilone is marketed as Cesamet. It was approved in 1985 by the U.S. Food and Drug Administration (FDA) for treatment of chemotherapy-induced nausea and vomiting that has not responded to conventional antiemetics.
Science and Research
Undated - Monograph ~ GENERIC NAME: NABILONE - ORAL (NAB-ih-lone)
Brand Names : Cesamet
2012 - Study ~ A
Randomized, Double-Blind, Placebo Controlled, Parallel Assignment,
Flexible Dose, Efficacy Study of Nabilone as Adjuvant in the Treatment
of Diabetic Peripheral Neuropathic Pain Using an Enriched Enrollment
Randomized Withdrawal Design
2008 - Study ~ Cannabinoids in the management of difficult to treat pain
2008 - Study ~ Nabilone for the treatment of pain in fibromyalgia.
2008 - News ~ Marijuana Derivative Called Effective in Fibromyalgia
2008 - Study ~ Two New Approaches for Fibromyalgia
2007 - Study ~ Cesamet (nabilone) capsule
2007 - News ~ Synthetic Cannabis for Fibromyalgia Pain?2007 - News ~ Nabilone relieves many advanced Ca symptoms
2006 - Study ~ Nabilone significantly reduces spasticity-related pain
2006 - News ~ 2nd synthetic marijuana drug OK'd for chemo effects
2003 - Study ~ Therapeutic potential of cannabinoids in CNS disease.
2002 - Study ~ Cannabinoids and multiple sclerosis.
2001 - Study ~ Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study.
2000 - Study ~ Different effects of nabilone and cannabidiol on binocular depth inversion in Man.
1995 - Study ~ Nabilone in the treatment of multiple sclerosis.
1988 - Study ~ A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues.1987 - Study ~ A double-blind randomised cross-over comparison of nabilone and metoclopramide in the control of radiation-induced nausea.
1986 - Study ~ Nabilone: an alternative antiemetic for cancer chemotherapy.
1985 - Study ~ A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy.1983 - Study ~ Respiratory and cardiovascular depressant effects of nabilone, N-methyllevonantradol and delta 9-tetrahydrocannabinol in anesthetized cats.1982 - Study ~ A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting.
1980 - Study ~ Cannabinoids. II. Cardiovascular Effects1980 - Study ~ Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis.